Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213355954> ?p ?o ?g. }
- W4213355954 endingPage "e12975" @default.
- W4213355954 startingPage "e12975" @default.
- W4213355954 abstract "This study aimed to conduct a network meta-analysis (NMA) to compare the efficacy of brain natriuretic peptide (BNP) vs nicorandil for preventing contrast-induced nephropathy (CIN). Databases of Pubmed, Cochrane, Embase, Web of Science were searched by keywords for eligible studies of randomized controlled trials investigating different agents (BNP, nicorandil, nitroglycerin, intravenous saline) for preventing CIN. The outcomes included a change in serum creatinine level at 48 h and the incidence of CIN after percutaneous coronary intervention (PCI) or coronary angiography (CAG). A total of 13 studies with 3,462 patients were included. Compared with intravenous saline alone, except for nitroglycerin (odds ratio [OR]: 1.02, 95% CI [0.36–2.88]), the other drugs significantly reduced the CIN incidence with OR of 0.35 (95% CI [0.24–0.51]) for BNP, 0.52 (0.29, 0.94) for usual-dose nicorandil, 0.28 (0.19, 0.43) for double-dose nicorandil. BNP and double-dose nicorandil significantly decreased the change of serum creatinine (SCr) levels with mean difference (MD) of −6.98, (−10.01, −3.95) for BNP, −8.78, (−11.63, −5.93) for double-dose nicorandil. No significant differences were observed in the change of SCr levels for nitroglycerin (−4.97, [−11.46, 1.52]) and usual-dose nicorandil (−2.32, [−5.52, 0.89]) compared with intravenous saline alone. For double-dose nicorandil, the CIN incidence and the change of SCr level in group of 4–5 days treatment course were more than group of less than or equal to 24 h treatment course (OR of 1.48, [0.63–3.46] and MD of 2.48, [−1.96, 6.91]). In conclusion, BNP and double-dose nicorandil can have effects on preventing the incidence of CIN and double-dose nicorandil performed better than BNP. In double-dose nicorandil groups, a course of less than or equal to 24 h before and after procedure performed with better efficacy than a course of 4–5 days." @default.
- W4213355954 created "2022-02-24" @default.
- W4213355954 creator A5006382818 @default.
- W4213355954 creator A5011454527 @default.
- W4213355954 creator A5017590815 @default.
- W4213355954 creator A5026058754 @default.
- W4213355954 creator A5058011950 @default.
- W4213355954 creator A5060989669 @default.
- W4213355954 creator A5068761606 @default.
- W4213355954 creator A5085248434 @default.
- W4213355954 date "2022-02-23" @default.
- W4213355954 modified "2023-09-30" @default.
- W4213355954 title "Efficacy of brain natriuretic peptide vs. nicorandil in preventing contrast-induced nephropathy: a network meta-analysis" @default.
- W4213355954 cites W1480735586 @default.
- W4213355954 cites W1514836144 @default.
- W4213355954 cites W1968686886 @default.
- W4213355954 cites W2014990046 @default.
- W4213355954 cites W2018305848 @default.
- W4213355954 cites W2050044991 @default.
- W4213355954 cites W2058245391 @default.
- W4213355954 cites W2058345758 @default.
- W4213355954 cites W2123528488 @default.
- W4213355954 cites W2127911797 @default.
- W4213355954 cites W2132143551 @default.
- W4213355954 cites W2154077041 @default.
- W4213355954 cites W2256639800 @default.
- W4213355954 cites W2265244460 @default.
- W4213355954 cites W2289579554 @default.
- W4213355954 cites W2299554199 @default.
- W4213355954 cites W2485135148 @default.
- W4213355954 cites W2525939095 @default.
- W4213355954 cites W2550723304 @default.
- W4213355954 cites W2594577164 @default.
- W4213355954 cites W2605065366 @default.
- W4213355954 cites W2617275753 @default.
- W4213355954 cites W2939990562 @default.
- W4213355954 cites W2942811083 @default.
- W4213355954 cites W2981674300 @default.
- W4213355954 cites W2982656436 @default.
- W4213355954 cites W3000139361 @default.
- W4213355954 cites W3008868418 @default.
- W4213355954 cites W3083179409 @default.
- W4213355954 cites W4255466401 @default.
- W4213355954 cites W4293395659 @default.
- W4213355954 cites W4362203616 @default.
- W4213355954 cites W72705582 @default.
- W4213355954 cites W2966125503 @default.
- W4213355954 doi "https://doi.org/10.7717/peerj.12975" @default.
- W4213355954 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35228908" @default.
- W4213355954 hasPublicationYear "2022" @default.
- W4213355954 type Work @default.
- W4213355954 citedByCount "1" @default.
- W4213355954 countsByYear W42133559542023 @default.
- W4213355954 crossrefType "journal-article" @default.
- W4213355954 hasAuthorship W4213355954A5006382818 @default.
- W4213355954 hasAuthorship W4213355954A5011454527 @default.
- W4213355954 hasAuthorship W4213355954A5017590815 @default.
- W4213355954 hasAuthorship W4213355954A5026058754 @default.
- W4213355954 hasAuthorship W4213355954A5058011950 @default.
- W4213355954 hasAuthorship W4213355954A5060989669 @default.
- W4213355954 hasAuthorship W4213355954A5068761606 @default.
- W4213355954 hasAuthorship W4213355954A5085248434 @default.
- W4213355954 hasBestOaLocation W42133559541 @default.
- W4213355954 hasConcept C126322002 @default.
- W4213355954 hasConcept C134018914 @default.
- W4213355954 hasConcept C164705383 @default.
- W4213355954 hasConcept C2775846464 @default.
- W4213355954 hasConcept C2775915353 @default.
- W4213355954 hasConcept C2778198053 @default.
- W4213355954 hasConcept C2778569047 @default.
- W4213355954 hasConcept C2778902376 @default.
- W4213355954 hasConcept C2780306776 @default.
- W4213355954 hasConcept C2780400711 @default.
- W4213355954 hasConcept C2781184683 @default.
- W4213355954 hasConcept C45393284 @default.
- W4213355954 hasConcept C500558357 @default.
- W4213355954 hasConcept C555293320 @default.
- W4213355954 hasConcept C71924100 @default.
- W4213355954 hasConcept C95190672 @default.
- W4213355954 hasConceptScore W4213355954C126322002 @default.
- W4213355954 hasConceptScore W4213355954C134018914 @default.
- W4213355954 hasConceptScore W4213355954C164705383 @default.
- W4213355954 hasConceptScore W4213355954C2775846464 @default.
- W4213355954 hasConceptScore W4213355954C2775915353 @default.
- W4213355954 hasConceptScore W4213355954C2778198053 @default.
- W4213355954 hasConceptScore W4213355954C2778569047 @default.
- W4213355954 hasConceptScore W4213355954C2778902376 @default.
- W4213355954 hasConceptScore W4213355954C2780306776 @default.
- W4213355954 hasConceptScore W4213355954C2780400711 @default.
- W4213355954 hasConceptScore W4213355954C2781184683 @default.
- W4213355954 hasConceptScore W4213355954C45393284 @default.
- W4213355954 hasConceptScore W4213355954C500558357 @default.
- W4213355954 hasConceptScore W4213355954C555293320 @default.
- W4213355954 hasConceptScore W4213355954C71924100 @default.
- W4213355954 hasConceptScore W4213355954C95190672 @default.
- W4213355954 hasFunder F4320332531 @default.
- W4213355954 hasLocation W42133559541 @default.
- W4213355954 hasLocation W42133559542 @default.